CL2011002302A1 - Uso de una composicion que comprende un monocaprina y un diluyente farmaceuticamente aceptable para el tratamiento de una condicion micotica causada por trichophyton rubrum tal como tinea pedis, tinea crusis, dermatofitosis y onicomicosis. - Google Patents
Uso de una composicion que comprende un monocaprina y un diluyente farmaceuticamente aceptable para el tratamiento de una condicion micotica causada por trichophyton rubrum tal como tinea pedis, tinea crusis, dermatofitosis y onicomicosis.Info
- Publication number
- CL2011002302A1 CL2011002302A1 CL2011002302A CL2011002302A CL2011002302A1 CL 2011002302 A1 CL2011002302 A1 CL 2011002302A1 CL 2011002302 A CL2011002302 A CL 2011002302A CL 2011002302 A CL2011002302 A CL 2011002302A CL 2011002302 A1 CL2011002302 A1 CL 2011002302A1
- Authority
- CL
- Chile
- Prior art keywords
- tinea
- onychomycosis
- treatment
- crusis
- monocaprine
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/045—Hydroxy compounds, e.g. alcohols; Salts thereof, e.g. alcoholates
- A61K31/05—Phenols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
- A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
- A01N31/00—Biocides, pest repellants or attractants, or plant growth regulators containing organic oxygen or sulfur compounds
- A01N31/08—Oxygen or sulfur directly attached to an aromatic ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
- A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/10—Dispersions; Emulsions
- A61K9/12—Aerosols; Foams
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
- A61K9/7015—Drug-containing film-forming compositions, e.g. spray-on
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/10—Antimycotics
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Dispersion Chemistry (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Pest Control & Pesticides (AREA)
- Agronomy & Crop Science (AREA)
- Plant Pathology (AREA)
- Dentistry (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Environmental Sciences (AREA)
- Medicinal Preparation (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Método para el tratamiento o profilaxis de una condición micótica; composición farmacéutica que comprende un monoéster de ácido graso de glicerol y un segundo agente farmacéuticamente activo; uso para tratar tinea pedis, tinea cruis, dermatofisis y onicomicosis.
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US20263509P | 2009-03-20 | 2009-03-20 | |
US21331309P | 2009-05-28 | 2009-05-28 |
Publications (1)
Publication Number | Publication Date |
---|---|
CL2011002302A1 true CL2011002302A1 (es) | 2012-06-22 |
Family
ID=42740006
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CL2011002302A CL2011002302A1 (es) | 2009-03-20 | 2011-09-16 | Uso de una composicion que comprende un monocaprina y un diluyente farmaceuticamente aceptable para el tratamiento de una condicion micotica causada por trichophyton rubrum tal como tinea pedis, tinea crusis, dermatofitosis y onicomicosis. |
Country Status (15)
Country | Link |
---|---|
US (2) | US20110305646A1 (es) |
EP (1) | EP2408299B1 (es) |
JP (1) | JP5992324B2 (es) |
KR (1) | KR101506369B1 (es) |
CN (1) | CN102368904B (es) |
AU (1) | AU2010226476B2 (es) |
BR (1) | BRPI1014529A2 (es) |
CA (1) | CA2756047C (es) |
CL (1) | CL2011002302A1 (es) |
EA (1) | EA022569B1 (es) |
ES (1) | ES2437395T3 (es) |
IL (1) | IL214887A (es) |
MX (1) | MX2011009781A (es) |
PL (1) | PL2408299T3 (es) |
WO (1) | WO2010108060A1 (es) |
Families Citing this family (12)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
ES2548998T3 (es) * | 2009-05-29 | 2015-10-22 | Palau Pharma, S.A. | Composiciones antifúngicas de azol |
CA2775393C (en) * | 2012-05-02 | 2014-04-29 | Samy Saad | Topical non-aqueous pharmaceutical formulations |
US8778365B1 (en) | 2013-01-31 | 2014-07-15 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9446131B2 (en) | 2013-01-31 | 2016-09-20 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9452173B2 (en) | 2013-01-31 | 2016-09-27 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
US9433680B2 (en) | 2013-01-31 | 2016-09-06 | Merz Pharmaceuticals, Llc | Topical compositions and methods for making and using same |
JP6125718B2 (ja) * | 2014-03-26 | 2017-05-10 | 株式会社マンダム | デオドラント組成物及びデオドラント剤 |
CN104672506A (zh) * | 2015-02-02 | 2015-06-03 | 安徽玉堂雨具有限公司 | 一种抗菌防霉生物降解塑料及其制备方法 |
WO2017216722A2 (en) * | 2016-06-13 | 2017-12-21 | Vyome Biosciences Pvt. Ltd. | Synergistic antifungal compositions and methods thereof |
US20190142800A1 (en) * | 2016-06-13 | 2019-05-16 | Vyome Therapeutics Limited | Synergistic antifungal compositions and methods thereof |
EP4076391A1 (en) * | 2019-12-20 | 2022-10-26 | GlaxoSmithKline Consumer Healthcare Holdings (US) LLC | Topical pharmaceutical compositions for treating onychomycosis |
KR102442047B1 (ko) * | 2020-09-10 | 2022-09-08 | 서울대학교산학협력단 | 설페이트와 아민기를 함유하는 지방산 글리세리드 화합물, 이의 생산 방법, 및 용도 |
Family Cites Families (17)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4067997A (en) * | 1975-05-21 | 1978-01-10 | Med-Chem Laboratories | Synergistic microbecidal composition and method |
FR2613227B1 (fr) * | 1987-04-01 | 1990-12-28 | Oreal | Compositions pharmaceutiques a base de nitrate de miconazole ou de nitrate d'econazole dans le traitement des infections fongiques des ongles |
FI912955A (fi) * | 1990-06-25 | 1991-12-26 | Res Found Mental Hygiene | Antimikroba fettsyrasammansaettningar. |
HU219480B (hu) * | 1991-05-23 | 2001-04-28 | Novartis Ag. | Eljárás gombás körömmegbetegségek ellen helyileg alkalmazható, allil-amin-származékot tartalmazó gyógyászati készítmények előállítására |
DE4434781A1 (de) * | 1994-09-29 | 1996-04-04 | Beiersdorf Ag | Verwendung von Fettsäureestern zur Bekämpfung von Superinfektionen |
RU2122402C1 (ru) * | 1995-07-18 | 1998-11-27 | Научно-производственная фирма "Фаркос" Товарищество с ограниченной ответственностью | Средство для лечения и профилактики грибковых заболеваний кожи на основе гризеофульвина |
DE19540465A1 (de) * | 1995-10-30 | 1997-05-07 | Beiersdorf Ag | Antimycotische Zubereitungen mit einem wirksamen Gehalt an Fettsäurepartialglyceriden |
DK0983037T3 (da) * | 1998-02-09 | 2003-09-01 | Macrochem Corp | Fungicid neglelak |
NZ520749A (en) * | 2000-02-16 | 2004-06-25 | Bentley Pharmaceuticals Inc | Pharmaceutical composition comprising a drug, a membrane-compatible permeation enhancer and a polymeric film-forming agent |
JP2004043336A (ja) * | 2002-07-10 | 2004-02-12 | Naris Cosmetics Co Ltd | 抗菌剤及びそれを配合してなる化粧料 |
MX265090B (es) * | 2002-07-22 | 2009-03-13 | Ciba Sc Holding Ag | Copolimeros y su empleo en composiciones para el cuidado personal. |
US20050165104A1 (en) * | 2002-07-24 | 2005-07-28 | Holwerda James G. | Biocidal agents and veterinary methods |
EP1633818A2 (en) * | 2003-04-18 | 2006-03-15 | MERCK PATENT GmbH | Antimicrobial pigments |
US20050058673A1 (en) * | 2003-09-09 | 2005-03-17 | 3M Innovative Properties Company | Antimicrobial compositions and methods |
US8796332B2 (en) * | 2004-08-03 | 2014-08-05 | Regents Of The University Of Minnesota | Compositions and methods for controlling infections |
RU2337689C1 (ru) * | 2007-04-18 | 2008-11-10 | Общество с ограниченной ответственностью "Фармацевтические технологии" | Средство для лечения поверхностных микозов |
WO2009132342A1 (en) * | 2008-04-25 | 2009-10-29 | Nanobio Corporation | Nanoemulsions for treating fungal, yeast and mold infections |
-
2010
- 2010-03-19 WO PCT/US2010/027905 patent/WO2010108060A1/en active Application Filing
- 2010-03-19 MX MX2011009781A patent/MX2011009781A/es active IP Right Grant
- 2010-03-19 AU AU2010226476A patent/AU2010226476B2/en active Active
- 2010-03-19 CN CN201080012652.7A patent/CN102368904B/zh active Active
- 2010-03-19 CA CA2756047A patent/CA2756047C/en not_active Expired - Fee Related
- 2010-03-19 EA EA201171150A patent/EA022569B1/ru not_active IP Right Cessation
- 2010-03-19 BR BRPI1014529-0A patent/BRPI1014529A2/pt not_active Application Discontinuation
- 2010-03-19 PL PL10754148T patent/PL2408299T3/pl unknown
- 2010-03-19 ES ES10754148.4T patent/ES2437395T3/es active Active
- 2010-03-19 US US13/202,780 patent/US20110305646A1/en not_active Abandoned
- 2010-03-19 KR KR1020117021776A patent/KR101506369B1/ko active IP Right Grant
- 2010-03-19 EP EP10754148.4A patent/EP2408299B1/en active Active
- 2010-03-19 JP JP2012500982A patent/JP5992324B2/ja active Active
-
2011
- 2011-08-29 IL IL214887A patent/IL214887A/en active IP Right Grant
- 2011-09-16 CL CL2011002302A patent/CL2011002302A1/es unknown
-
2018
- 2018-02-22 US US15/901,996 patent/US20180360791A1/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO2010108060A8 (en) | 2011-12-29 |
ES2437395T3 (es) | 2014-01-10 |
PL2408299T3 (pl) | 2014-03-31 |
KR101506369B1 (ko) | 2015-03-30 |
EP2408299B1 (en) | 2013-10-23 |
IL214887A (en) | 2015-09-24 |
JP2012521351A (ja) | 2012-09-13 |
AU2010226476A1 (en) | 2011-09-22 |
AU2010226476B2 (en) | 2013-02-07 |
JP5992324B2 (ja) | 2016-09-14 |
EA022569B1 (ru) | 2016-01-29 |
CN102368904B (zh) | 2014-03-26 |
EP2408299A4 (en) | 2012-08-15 |
EP2408299A1 (en) | 2012-01-25 |
CA2756047A1 (en) | 2010-09-23 |
EA201171150A1 (ru) | 2012-03-30 |
MX2011009781A (es) | 2011-10-17 |
BRPI1014529A2 (pt) | 2015-08-25 |
IL214887A0 (en) | 2011-11-30 |
CN102368904A (zh) | 2012-03-07 |
US20110305646A1 (en) | 2011-12-15 |
US20180360791A1 (en) | 2018-12-20 |
KR20120014553A (ko) | 2012-02-17 |
CA2756047C (en) | 2016-04-26 |
WO2010108060A1 (en) | 2010-09-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
CL2011002302A1 (es) | Uso de una composicion que comprende un monocaprina y un diluyente farmaceuticamente aceptable para el tratamiento de una condicion micotica causada por trichophyton rubrum tal como tinea pedis, tinea crusis, dermatofitosis y onicomicosis. | |
CO2018001375A2 (es) | Composiciones de retinoides tópicos | |
ECSP23041058A (es) | Formulación subcutánea de anticuerpo anti-her2 | |
DOP2017000137A (es) | Benzamidas sustituidas con 1,3tiazol2ilo. | |
PE20140255A1 (es) | Tableta dispersable en forma oral | |
CL2011002053A1 (es) | Composicion farmaceutica de espuma en aerosol en emulsion de aceite en agua que comprende un agente farmaceuticamente activo, agua, aceite, disolvente organico, componente tensoactivo, y propulsor; procedimiento de preparacion; uso para tratar enfermedades, o afecciones de la piel. | |
CL2011002648A1 (es) | Composicion topica que comprende un compuesto derivado de 1,2,4-tiadiazol o tiourea, un agente modificador de la viscosidad, un conservante y agua; estuche para la composicion; metodo para preparar la composicion; y uso para tratar una enfermedad o trastorno dermatologico mediado por un receptor de melanocortina tal como acne. | |
AR089578A1 (es) | Composiciones, metodos para tratar el virus de la hepatitis c y proceso de preparacion | |
UY33598A (es) | Imidazopiridazinas sustituidas | |
UY35040A (es) | Pirrolopirimidinilamino-benzotiazolonas sustituidas | |
EA201170876A1 (ru) | Применение способной к вспениванию композиции, по существу, не содержащей фармацевтически активные ингредиенты, для лечения кожи человека | |
ECSP13013117A (es) | Métodos para tratar la esclerosis múltiple y preservar y/o aumentar el contenido de mielina. | |
CO6511229A2 (es) | Metodos para reducir la actividad viricida en composiciones pcv-2 y composiciones pcv-2 con una inmunogeicidad mejorada | |
DOP2016000118A (es) | Tienopirimidinas como inhibidores mknk1 y mknk2 | |
PE20121709A1 (es) | Una composicion farmaceutica para tratar cancer que comprende tripsinogeno y/o quimotripsinogeno y un agente activo seleccionado a partir de un compuesto de selenio, un compuesto vainilloide y un agente reductor de glicolisis citoplasmica | |
MX2011012143A (es) | Composiciones adecuadas para el tratamiento topico o infecciones fungicas de la piel y uñas. | |
ECSP18042091A (es) | Composición para cuidado y protección de cultivos | |
MX2012005689A (es) | Analogos de acido araquidonico y metodos para el tratamiento analgesico utilizando los mismos. | |
CO7170176A2 (es) | Nuevo compuesto que tiene la capacidad para inhibir la enzima deshidrogenasa11b-hidroxiesteroide tipo 1(11b-hsd1) o sal farmaceúticamente aceptable del mismo, método para producir el mismo, y composición farmaceútica que contiene el mismo como ingrediente activo | |
AR075274A1 (es) | Agente de tratamiento de semillas y metodo para proteger una planta | |
DOP2016000007A (es) | Pirazolpiridinas sustituidas | |
BR112012027080A2 (pt) | composições orgânicas para tratar doenças relacionadas a beta - ena | |
CL2014002591A1 (es) | Composicion topica semisolida que comprende pirfenidona, dialil oxido de disulfuro modificado (odd-m), un agente gelificante y otros excipientes o aditivos; proceso para fabricarla; metodo de tratamiento; y su uso para eliminar, reducir o prevenir el acne. | |
AR087075A1 (es) | Composiciones para el cuidado personal, un compuesto activo | |
AR087790A1 (es) | Uso de un inhibidor de aromatasa para el tratamiento de hipogonadismo y enfermedades relacionadas |